Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00818116 · ClinicalTrials.gov registry record · Phase 4
Visual Function Evaluation of Bilateral AcrySof ReSTOR Aspheric IOL
A Phase 4 study, sponsored by Alcon Research.
- Completed
- Registry status
- Phase 4
- Development phase
- 34
- Enrollment target
NCT00818116 is a Phase 4 study that has completed, run by Alcon Research. The registered enrollment target is 34 participants.
The verdict
NCT00818116, a Phase 4 study, has completed, sponsored by Alcon Research.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 34 participants
- Enrollment target
Study Summary
The objective of this study is to evaluate postoperative visual function in patients implanted bilaterally with the ReSTOR Aspheric Intraocular Lens (IOL).
Interventions
- DEVICE AcrySof ReSTOR Aspheric IOL
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2008-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00818116
The ClinicalTrials.gov registry entry for NCT00818116 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Alcon Research, which has 275 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which AcrySof ReSTOR Aspheric IOL is the first listed.
NCT00818116 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00818116 about?
NCT00818116 is a clinical study titled "Visual Function Evaluation of Bilateral AcrySof ReSTOR Aspheric IOL". The objective of this study is to evaluate postoperative visual function in patients implanted bilaterally with the ReSTOR Aspheric Intraocular Lens (IOL).
What is the current status of trial NCT00818116?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 34 participants. The study started on 2008-12.
What interventions are being tested in trial NCT00818116?
The interventions under investigation include: AcrySof ReSTOR Aspheric IOL (DEVICE).
Who is sponsoring clinical trial NCT00818116?
This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.